Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank54
3Y CAGR+0.7%
5Y CAGR+6.0%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+0.7%/yr
vs -35.2%/yr prior
5Y CAGR
+6.0%/yr
Recent deceleration
Acceleration
+35.9pp
Accelerating
Percentile
P54
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 35.09% |
| 2024 | 22.78% |
| 2023 | 27.71% |
| 2022 | 34.38% |
| 2021 | 48.48% |
| 2020 | 26.20% |
| 2019 | 30.16% |
| 2018 | 195.02% |
| 2017 | 50.82% |
| 2016 | 84.26% |